Overall, these results demonstrate that high levels of IL-6/sIL-6R, as those present in joints of patients with arthritis, may contribute to the amplification of the inflammatory response enhancing the production of IL-1β, CXCL8 and CCL2 by SFMCs and by RA synoviocytes. The gene discussed is CCL2; the disease is arthritic joint disease.